Skip to main navigation Skip to search Skip to main content

Mb130-069 (Falcon 2) - A Phase 2b Randomized, Double-Blind, Placebo-Controlled Study Evaluating The Safety And Efficacy Of Bms-986036 (Peg-Fgf21) In Adults With Nonalcoholic Steatohepatitis (Nash) And Compensated Liver Cirrhosis

Project: Research

Project Details

StatusFinished
Effective start/end date02/21/19 → 02/21/24

Funding

  • Pharmaceutical Research Associates Incorporated: $110,780.00